世界の分子遺伝学・癌・法医学・親子鑑定検査市場2021:アメリカ、ヨーロッパ、日本–サプライヤー販売・シェア、規模・販売セグメント予測、競争分析、新技術、最新装置、成長機会

◆英語タイトル:2021 Global Molecular Genetic, Cancer, Forensic and Paternity Testing Market: US, Europe, Japan--Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities

Venture Planning Groupが発行した調査報告書(VPG21AG035)◆商品コード:VPG21AG035
◆発行会社(リサーチ会社):Venture Planning Group
◆発行日:2021年7月
◆ページ数:570
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Local PDFUSD7,500 ⇒換算¥1,095,000見積依頼/購入/質問フォーム
Global PDFUSD9,500 ⇒換算¥1,387,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

This new seven-country study from VPGMarketResearch contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

- Market shares of leading suppliers
- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. ; Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Five-year test volume and sales projections:

- Infectious Diseases        - Forensic Testing
-Cancer                            – Paternity Testing/HLA Typing
- Genetic Diseases            - Others

- A comprehensive analysis of the sequencing market by country and laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Product/Technology Review

- Comparison of the major molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

- Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.

Contains 570 pages and 42 tables

❖ レポートの目次 ❖

Introduction
Global Market Trends and Emerging Technologies
A. DNA Sequencing
B. DNA and RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing
1. Overview
2. Major Cancer Types
3. Oncogenes
H. Genetic Diseases Molecular Diagnostic Testing
1. Overview
2. Nucleic Acid Amplification
3. Chromosome Imaging
4. Genomics Technologies
5. Proteomics Technologies
6. Current Pharmacogenomic Testing
7. Major Diseases
I. Forensic Molecular Diagnostics Testing
1. Overview
2. Multilocus and Single Locus Probes
3. The FBI
4. DNA Profile Data Banks
5. Judicial Implementation
6. Major Crime Categories
7. Factors Contributing to the DNA Probe
Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies
M. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
U.S.A.
A. Executive Summary
B. Business Environment and Healthcare Reform
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Market Segment
- Sales Forecasts by Market Segment
- Major Supplier Sales and Market Shares
Major Product Development Opportunities
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
Potential Market Entry Barriers And Risks
Competitive Profiles
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- Decode Genetics
- Diadexus
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic
- Illumina
- LabCorp
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- PerkinElmer
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher

http://www.vpgcorp.com/webfiles/DNA/TOCLOT%20GlobalGeneticDiseasesCancerForensicandPaternityMolecularDiagnosticTestingMarkets.pdf

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の分子遺伝学・癌・法医学・親子鑑定検査市場2021:アメリカ、ヨーロッパ、日本–サプライヤー販売・シェア、規模・販売セグメント予測、競争分析、新技術、最新装置、成長機会(2021 Global Molecular Genetic, Cancer, Forensic and Paternity Testing Market: US, Europe, Japan--Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆